We partner with clients to design and implement strategies for customers that enhance accessibility, while accounting for factors such as market dynamics, unique product and portfolio factors, organizational culture, and internal operations.
We help clients assess current market and policy trends; healthcare system nuances, specifically around pricing and reimbursement; key customers and influencers; and provide actionable recommendations to inform product and portfolio access strategies.
We partner with teams to develop an operational roadmap for value, price, and contracting strategies by structuring market research plans, creating tools and processes for contracting, and defining key partnerships and activities required for sustainable access.
We help market access teams execute payer marketing strategy by developing tailored customer engagement plans and defining success measures to evaluate engagement.
We partner with market access teams to effectively articulate the vision across markets, regions, and divisions, define key priorities, and mobilize critical activities with nuance based on the market landscape and internal operations.
We work with clients to assess current operating model and structures, define requirements, and make recommendations based on the unique culture of the organization, with a key focus on ensuring appropriate cross-functional collaboration and integration of market access teams with internal functions.
We help clients develop effective market access strategies by supporting the evaluation of current state, determining business requirements – leveraging industry best practices – and evaluating in-house and outsourced options and vendors for customized recommendations related to data infrastructure needs.
Get an inside look at the way we work and how we think about the most pressing challenges our Life Sciences clients are facing. Check out our latest insights, case studies, and podcast episodes.
While awaiting approval to launch a new product, a large pharmaceutical company identified a need to revisit their market access strategy.
To address the challenges associated with an increased demand for specialty care, Vynamic recommends a parallel commercial operations approach.
Our global life sciences client faced a market dynamic increasingly focused on discounting medications with payers.